Melatonin Dose Paradox: Why 0.3 mg Often Beats 5-10 mg in 2026

Melatonin is the most misdosed supplement in the United States. The typical OTC tablet contains 3, 5, or 10 milligrams — up to 30 times the physiological pre-sleep blood concentration. Yet Brzezinski et al. (2005) Sleep Medicine Reviews and subsequent meta-analyses consistently show that 0.3 to 1 mg produces the same or better sleep-onset effect with less next-day grogginess. Higher doses drive plasma levels into the pharmacological range, promote receptor desensitization, and leak unmetabolized melatonin into morning hours, worsening the grogginess that drove dose escalation in the first place. Europe largely avoided this mess by regulating melatonin as a 2 mg prescription extended-release product (Circadin). In 2026 the evidence for the low-dose approach is strong — and so is the evidence that US OTC melatonin products vary up to 478% from labeled content. This guide covers what melatonin actually does, where it works, and how to dose it correctly.

What Melatonin Is (and Isn't)

Melatonin is a pineal-gland hormone that signals night. It is not primarily a sedative; it is a circadian phase-shift agent. The strongest evidence is for jet lag, delayed sleep phase syndrome, shift work sleep disorder, and the elderly (where endogenous production drops). It is weaker or absent for primary insomnia with normal circadian timing and for sleep maintenance.

The Dose Paradox

Brzezinski 2005 meta-analysis

Brzezinski et al. (2005) Sleep Medicine Reviews pooled RCTs and found modest sleep-onset improvement with melatonin, with no clear dose-response above 0.3-0.5 mg. Lower doses produced plasma profiles approximating natural nighttime levels; higher doses produced supraphysiological levels lasting into morning.

Receptor desensitization

MT1 and MT2 receptor desensitization with chronic high-dose exposure is described in animal models and consistent with clinical reports of diminishing returns. Lewy & Sack work in the 1990s established that very low doses (0.1-0.5 mg) can reliably shift circadian phase.

Why the US sells 5-10 mg

In the United States, melatonin is a dietary supplement; no regulatory upper limit applies, and consumer preference for "more is better" drives product formulation. The clinical evidence did not drive the market.

Regulation: US vs Europe

In Europe, melatonin above 1 mg is typically a medicine. Circadin (2 mg extended-release) is licensed for short-term insomnia in adults 55+. In the US, melatonin is sold freely at 1-20 mg doses. Australia classifies melatonin above 2 mg as Schedule 4 (prescription). This regulatory split matters for travelers importing supplements.

The Label Accuracy Problem

Erland & Saxena (2017) Journal of Clinical Sleep Medicine tested 31 Canadian melatonin supplements and found content ranging from -83% to +478% of labeled dose; serotonin contamination was present in some products. ConsumerLab and LabDoor independent testing over subsequent years have found similar patterns, particularly in gummies and combination products. Third-party certification (USP, NSF) matters here more than almost any other category.

Table: Melatonin by use case

Use case	Optimal dose	Timing	Formulation
Jet lag (eastward flights)	0.5-3 mg	Local bedtime on arrival, 3-5 nights	Immediate-release
Delayed sleep phase	0.3-0.5 mg	4-6 hours before desired bedtime	Immediate-release
Shift work	0.5-3 mg	Before daytime sleep	Immediate-release
Age-related insomnia 55+	2 mg	30-60 min pre-bed	Extended-release (Circadin-style)
Primary insomnia (young adults)	Limited evidence	—	Not first line
Sleep-maintenance insomnia	Not effective	—	Use alternatives
Pediatric (clinician-only)	0.3-3 mg	Clinician supervised	Immediate-release

Pediatric Cautions

American Academy of Pediatrics and the American Academy of Sleep Medicine have issued cautions on routine pediatric melatonin use. A 2022 JAMA study by Hartz et al. reported a 530% rise in US pediatric melatonin overdose calls to poison control over the prior decade, driven partly by gummy products indistinguishable from candy. Short-term clinician-supervised use in neurodevelopmental conditions (ASD, ADHD) has evidence; routine use as a bedtime habit does not.

Who Benefits, Who Doesn't

Melatonin is effective for phase-shifting and for age-related endogenous decline. It is largely ineffective for anxiety-driven insomnia, chronic maintenance insomnia, and for most young adults with normal circadian timing who simply can't sleep. Pairing melatonin with good sleep hygiene, light management, and (when indicated) CBT-I is more productive than dose escalation.

Side Effects and Interactions

Common effects: vivid dreams, morning grogginess (dose-dependent), headache. Interactions: melatonin can interact with anticoagulants, immunosuppressants, diabetes medications, and some antiseizure drugs. Avoid co-use with alcohol and benzodiazepines unless clinician-supervised.

Nutrola Approach

Nutrola's supplement ratings penalize high-dose melatonin products and flag third-party-verified low-dose and extended-release options. The Nutrola app (from EUR 2.50/month, zero ads, 4.9 / 1,340,080 reviews) tracks your sleep timing and light exposure alongside supplement logging, which is the correct frame for melatonin — it is a circadian tool, not a hypnotic.

Medical Disclaimer

Chronic insomnia warrants medical evaluation. Do not give melatonin to children without clinician guidance. If you take anticoagulants, immunosuppressants, or have a seizure disorder, consult a prescriber.

Frequently Asked Questions

Will 10 mg knock me out faster than 0.5 mg?

No, not reliably. Higher doses often produce more morning grogginess without faster sleep onset.

Is melatonin addictive?

Tolerance and receptor desensitization can occur; physical dependence of the benzodiazepine type does not.

Can I take melatonin every night forever?

Long-term safety data are mostly reassuring at low doses; clinical guidelines still recommend short-term or phase-shift use.

Does melatonin help sleep maintenance (waking at 3 a.m.)?

Immediate-release melatonin: no. Extended-release 2 mg formulations: modest effect in older adults.

Why do European melatonin products feel different?

They are typically prescription-grade 2 mg extended-release, manufactured to pharmaceutical specs, with more reliable pharmacokinetics than US OTC tablets.

Can I overdose on melatonin?

Acute toxicity is uncommon, but very high doses, especially in children, produce lethargy and require evaluation. The pediatric surge in poison-control calls is a real concern.

References

• Brzezinski A et al. (2005) Sleep Medicine Reviews — Melatonin dose meta-analysis.
• Erland LAE, Saxena PK (2017) Journal of Clinical Sleep Medicine — Melatonin label accuracy study.
• Hartz I et al. (2022) JAMA — Pediatric melatonin ingestion calls to poison control.
• Lewy AJ, Sack RL (1997) Chronobiology International — Melatonin phase-shift pharmacology.
• Ferracioli-Oda E et al. (2013) PLoS One — Melatonin meta-analysis for primary sleep disorders.
• Wade AG et al. (2010) Current Medical Research and Opinion — Prolonged-release melatonin (Circadin) trial.